semaglutide patents Off-patent in 2026: the next revolution in anti-obesity medications A Snapshot of the Semaglutide

being kindly greeted by the front desk beauty who offered me me a beverage pointing to the cute little coffee bar set up

Effectiveness and evidence The strongest, most reproducible evidence for weight loss comes from prescription injectable GLP-1 therapies like semaglutide and tirzepatide, with multiple large randomized trials showing significant weight reduction and metabolic benefits

By functioning as a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist, Zepbound targets specific areas of the brain that control hunger and satiety

N Engl J Med 387:205216

Nakamura et al., 2025

Are the RetaOne Labs codes from the official online store